SPINOCEREBELLAR ATAXIAS
Clinical trials for SPINOCEREBELLAR ATAXIAS explained in plain language.
Never miss a new study
Get alerted when new SPINOCEREBELLAR ATAXIAS trials appear
Sign up with your email to follow new studies for SPINOCEREBELLAR ATAXIAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for SCA: Real-World data tests Troriluzole's power to slow disease
Disease control OngoingThis study looks at whether the drug troriluzole can slow the worsening of spinocerebellar ataxia (SCA), a rare brain disease that affects movement. Researchers compared 909 patients who took troriluzole for up to 3 years to similar patients who did not receive the drug. The goal…
Matched conditions: SPINOCEREBELLAR ATAXIAS
Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated May 26, 2026 11:13 UTC
-
Hope for ataxia: new pill aims to slow worsening of balance and speech
Disease control OngoingThis study tests whether a daily pill called troriluzole can help adults with spinocerebellar ataxia, a rare brain disease that affects balance, walking, and speech. About 300 participants took either the drug or a placebo for 48 weeks. The main goal was to see if the drug slows …
Matched conditions: SPINOCEREBELLAR ATAXIAS
Phase: PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 11:03 UTC
-
Mayo clinic launches massive ataxia gene study
Knowledge-focused OngoingThis study aims to collect blood or tissue samples and medical information from 1,000 adults with spinocerebellar ataxia or other nucleotide repeat diseases (excluding Huntington's disease), as well as their unaffected family members. The goal is to build a research repository to…
Matched conditions: SPINOCEREBELLAR ATAXIAS
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC
-
Smartphone app could reveal how exercise helps the brain in rare movement disorders
Knowledge-focused TerminatedThis study was designed to test a smartphone app called iBlink that measures a simple form of learning (eyeblink conditioning) in people with spinocerebellar ataxias, a group of rare brain disorders that affect movement. The goal was to see if aerobic exercise improves this learn…
Matched conditions: SPINOCEREBELLAR ATAXIAS
Phase: NA • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC